STOCK MARKET BSE NSE

Delhi recorded 1,858 black fungus cases so far; 686 active as on August 5: Health department

The Delhi government has also procured 26,700 vials of Liposomal Amphotericin B and 25,000 vials of Amphotericin B Lipid Complex.

Published: 08th August 2021 04:29 PM  |   Last Updated: 08th August 2021 04:29 PM   |  A+A-

black fungus, Mucormycosis

A doctor performs extended functional endoscopic sinus surgery on a person suffering from mucormycosis at a hospital in Ghaziabad. (File photo | AP)

By PTI

NEW DELHI: The national capital has so far recorded 1,858 mucormycosis (black fungus) cases, 686 of which were active as on August 5, the Delhi health department said on Sunday.

It said in a statement that the city has been allocated a total of 51,540 vials of Amphotericin-B for the treatment of the disease, out of which 42,960 vials "have been received and distributed to hospitals, and 8,080 vials are awaited".

"(The) Government of India has now discontinued the allocation and directed all State Governments to procure Amphotericin B Injection from the manufacturers directly as per their requirement," the statement said.

The Delhi government has also procured 26,700 vials of Liposomal Amphotericin B and 25,000 vials of Amphotericin B Lipid Complex, it said.

"Private hospitals are also now procuring directly from manufacturers," the statement added.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp